- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03381001
Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates
August 13, 2019 updated by: Selmo Geber, Federal University of Minas Gerais
Influence of Post-thaw Embryo Culture Interval Before Embryo Transfer on Assisted Reproduction Success Rates
The transfer of frozen / thawed embryos has been routinely performed in the last 30 years as part of Assisted Reproduction treatment (ART).
Currently, more than 50% of couples submitted to ART have surplus embryos eligible for freezing followed by transfer in subsequent cycles.
Therefore the selection criteria for the thawed embryos to be transferred must be rigorous in order to maximize pregnancy and of live birth rates.
Usually, the evaluation of the embryos before transfer can be performed based on blastomeres survival after a short culture period between thaw and embryos transfer, i.e., 2 to 5 hours, or based on embryo development over a prolonged period of culture (18h to 24h).
Post-thaw embryo culture might have an impact on the recovery of mitosis and normal cellular functions.
However, until now, there is no consensus in the literature on which post-thaw culture interval has a better impact on pregnancy and live birth rates.
Also, blastocysts formation after freezing/thawing of embryos at cleavage stage may bring relevant information about post-thaw culture.
Moreover, this strategy can be used as an alternative treatment.
Therefore, the authors proposed this prospective randomized, triple-blind study to evaluate the impact of post-thaw embryo culture on the pregnancy and live birth rates.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
268
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil, 30130100
- Hospital das Clínicas - Universidade Federal de Minas Gerais
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- patients submitted to ART treatment due to infertility that had frozen embryos and need an embryo transfer after endometrial preparation and embryo thawing
Exclusion Criteria:
- patients that does not reach criteria for frozen embryo transfer (thin endometrium, bleeding, inappropriate use of hormones)
- difficult embryo transfer
- embryos that were frozen twice
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: embryo transfer after embryo thaw
Embryos will be transferred at the same day of the thawing procedure
|
embryos will be transfer with no culture after thaw
|
|
EXPERIMENTAL: embryo transfer after thaw and culture
Embryos will be transferred one day after thawing procedure
|
embryos will be kept in culture after thawing for one day before transfer for the uterus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pregnancy rates
Time Frame: 8 weeks
|
percentage of patients that become pregnant after Frozen embryo transfer
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
implantation rate
Time Frame: 6 weeks
|
percentage of gestational sac according to the number of transferred embryos
|
6 weeks
|
|
embryo development
Time Frame: 24 hours
|
percentage of embryos that develop after thawing and before transfer
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, Checa MA. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. 2013 Jan;99(1):156-162. doi: 10.1016/j.fertnstert.2012.09.003. Epub 2012 Oct 3.
- Roque M, Valle M, Guimaraes F, Sampaio M, Geber S. Cost-Effectiveness of the Freeze-All Policy. JBRA Assist Reprod. 2015 Aug 1;19(3):125-30. doi: 10.5935/1518-0557.20150028.
- Roque M, Valle M, Guimaraes F, Sampaio M, Geber S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril. 2015 May;103(5):1190-3. doi: 10.1016/j.fertnstert.2015.01.045. Epub 2015 Mar 4.
- Roque M, Valle M, Guimaraes F, Sampaio M, Geber S. Freeze-all cycle for all normal responders? J Assist Reprod Genet. 2017 Feb;34(2):179-185. doi: 10.1007/s10815-016-0834-x. Epub 2016 Nov 5.
- Roque M, Valle M, Kostolias A, Sampaio M, Geber S. Freeze-all cycle in reproductive medicine: current perspectives. JBRA Assist Reprod. 2017 Feb 1;21(1):49-53. doi: 10.5935/1518-0557.20170012.
- Colodetti L, Pinho de Franca P, Sampaio M, Geber S. Do different culture intervals (2 x 24 hours) after thaw of cleavage stage embryos affect pregnancy rates? A randomized controlled trial. Cryobiology. 2020 Aug;95:80-83. doi: 10.1016/j.cryobiol.2020.06.002. Epub 2020 Jun 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2017
Primary Completion (ACTUAL)
June 15, 2019
Study Completion (ACTUAL)
August 10, 2019
Study Registration Dates
First Submitted
December 11, 2017
First Submitted That Met QC Criteria
December 20, 2017
First Posted (ACTUAL)
December 21, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 14, 2019
Last Update Submitted That Met QC Criteria
August 13, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TEC+1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
we don't have permission to share participant data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation
Clinical Trials on embryo transfer with no culture
-
Zeynep Kamil Maternity and Pediatric Research and...Completed
-
Vrije Universiteit BrusselTerminatedLive Birth Delivery RateBelgium
-
Bruce Shapiro M.D.Withdrawn
-
Mỹ Đức HospitalRecruitingPolycystic Ovary Syndrome (PCOS) | In Vitro Maturation of Oocytes | Fresh Embryo TransferVietnam
-
The University of Hong KongPeking University Third Hospital; Nanfang Hospital of Southern Medical University and other collaboratorsTerminated
-
University Hospital Virgen de las NievesInstituto de Salud Carlos IIICompletedInfertility | Pregnancy, MultipleSpain
-
Cairo UniversityRecruiting
-
Stanford UniversityCompleted
-
IgenomixUnknown
-
University Hospital Virgen de las NievesJunta de AndaluciaCompletedPregnancy Rate | Single Embryo Transfer | Embryo Implantation, DelayedSpain